The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.
Abstract
It is proposed that most neoplasms arise from a single cell of origin, and tumor progression results from acquired genetic variability within the original clone allowing sequential selection of more aggressive sublines. Tumor cell populations are apparently more genetically unstable than normal cells, perhaps from activation of specific gene loci in the neoplasm, continued presence of carcinogen, or even nutritional deficiencies within the tumor. The acquired genetic insta0ility and associated selection process, most readily recognized cytogenetically, results in advanced human malignancies being highly individual karyotypically and biologically. Hence, each patient's cancer may require individual specific therapy, and even this may be thwarted by emergence of a genetically variant subline resistant to the treatment. More research should be directed toward understanding and controlling the evolutionary process in tumors before it reaches the late stage usually seen in clinical cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations enabling rapid proliferation are selected positively in cancers because they accelerate the emergence of aggressive phenotypes through somatic evolution.1,2”
From Dynamic IL-6R/STAT3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells (2024) · cites this paper as [2]
Citations
Cites
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,592
Normal genetically mosaic mice produced from malignant teratocarcinoma cells.
Mintz, B., & Illmensee, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3585 · Cited by 1,179
Handbuch der allgemeinen pathologie
(1973) · Experimental Gerontology · doi:10.1016/0531-5565(73)90021-1 · Cited by 794
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 398
Differentiation of malignant to benign cells
Kauffman, S. A. (1971) · Journal of Theoretical Biology · doi:10.1016/0022-5193(71)90020-8 · Cited by 309
Suppression of malignancy in human cells
Stanbridge, E. J. (1976) · Nature · doi:10.1038/260017a0 · Cited by 307
Methodology in mammalian genetics
Burdette, W. J. (1963) · Holden-Day eBooks · doi:10.5962/bhl.title.6428 · Cited by 302
LEVAN, A., Levan, G., & Mitelman, F. (2009) · Hereditas · doi:10.1111/j.1601-5223.1977.tb01208.x · Cited by 263
The analysis of malignancy by cell fusion: I. hybrids between tumour cells and l cell derivatives
Klein, G., Bregula, U., Wiener, F., & Harris, H. (1971) · Journal of Cell Science · doi:10.1242/jcs.8.3.659 · Cited by 248
Neoplasia: a disease of cell differentiation.
Markert, C. L. (1968) · PubMed · Cited by 244
Flagged first, then by citations
1 of the 52 references couldn’t be matched to a known paper.
Research works printed but not linked: 24
- ALSAADI, A, SEQUENTIAL CYTOGENETIC CHANGES IN EVOLUTION OFTRANSPLANTED THYROID TUMORS IN METASTATIC CARCINOMA IN FICHER RAT, CANCER RESEARCH 27: 1831 (1967).
- BOYSE, E.A., CURRENT RES ONCOLOGY: 57 (1972).
- DIPAOLO, J.A., KARYOLOGICAL INSTABILITY OF NEOPLASTIC SOMATIC-CELLS, IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION 11: 89 (1975).
- FOLKMAN, J, S FUNDAMENTAL ASPECT: 331 (1975).
- FURTH, J, NATIONAL CANCER INSTITUTE MONOGRAPHS 2: 148 (1960).
- GERMAN, J, GENES WHICH INCREASE CHROMOSOMAL INSTABILITY IN SOMATIC CELLS AND PREDISPOSE TO CANCER, PROGRESS IN MEDICAL GENETICS 8: 61 (1972).
- GOLUB, S.H., CANCER COMPREHENSIVE 4: 259 (1975).
- GROUCHY, J.D., CHROMOSOMES CANCER: 287 (1974).
- HANDEN, D.G., CHROMOSOMES CANCER: 151 (1974).
- KLEIN, G, METHODOLOGY MAMMALIA: 407 (1963).
- KNUDSON, A.G., HEREDITY AND CANCER IN MAN, PROGRESS IN MEDICAL GENETICS 9: 113 (1973).
- MAKINO, S, ANN N Y ACAD SCI 64: 818 (1956).
- Miller, E. C., The Molecular Biology of Cancer: 377 (1974).
- NOWELL, P.C., CANCER COMPREHENSIVE 1: 3 (1975).
- NOWELL, P.C., CHROMOSOMES CANCER J: 267 (1974).
- ODELL, W, TXB ENDOCRINOLOGY: 1105 (1974).
- Oksala, T., Chromosomes and Cancer: 239 (1974).
- Pedersen, B., Proceedings of the Fourth International Congress on Human Genetics: 166 (1972).
- Pitot, H. C., Molecular Biology of Cancer: 523 (1974).
- Robbins, J. C., Cancer: A Comprehensive Treatise 4: 3 (1975).
- RUBIN, H, SCIENCE 191: 241 (1976). · DOI
- STICH, H.F., CANADIAN CANCER CONFERENCE 5: 99 (1963).
- WOLMAN, S.R., CANCER COMPREHENSIVE 3: 155 (1975).
- Yosida, T. H., Handbuch der Allgemeinen Pathologic: 677 (1975).
Cited by
Sorted by citations
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Metadata
- Authors
- Nowell, P. C.
- Affiliations
- School of Medicine, University of Pennsylvania, Philadelphia 19174.
- Venue
- Science
- Published
- 1976-10
- Volume
- 194
- Issue
- 4260
- Pages
- 23-28
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1967304777
- Cited by
- 6,471
- References
- 52
- Citations by year
- 2026: 117 · 2025: 163 · 2024: 183 · 2023: 201 · 2022: 209 · 2021: 282 · 2020: 287 · 2019: 259 · 2018: 304 · 2017: 332 · 2016: 263 · 2015: 261 · 2014: 241 · 2013: 233 · 2012: 200
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- clonal evolution, tumor progression, karyotypic heterogeneity, tumor cell populations, treatment resistance, carcinogen exposure, precision oncology
- MeSH terms
- Carcinogens, Chromosomes, Clone Cells, Karyotyping, Models, Biological, Mutation, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review